Establishing an Approach for Designation of Evolving and Emerging Drug Threats

Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, HR 6, 115th Cong (2018). Pub L No 115-271. https://www.congress.gov/bill/115th-congress/house-bill/6

Executive Office of the President, Office of National Drug Control Policy (ONDCP). Criteria for designating evolving and emerging drug threats. Dir No 2022-002. Accessed January 27, 2023. https://www.whitehouse.gov/wp-content/uploads/2023/01/Emerging-Threats-Criteria-Directive.pdf

US Centers for Disease Control and Prevention. SARS-CoV-2 variant classifications and definitions. Updated April 26, 2022. Accessed October 11, 2022. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html

Methamphetamine Response Act of 2021, S 854, 117th Cong (2022). Pub L No 117-99. https://www.congress.gov/bill/117th-congress/senate-bill/854/

Velazquez T , Remrey L. Methamphetamine use, overdose deaths, and arrests soared from 2015 to 2019. Pew Charitable Trusts. Published August 16, 2022. Accessed February 27, 2023. https://www.pewtrusts.org/en/research-and-analysis/articles/2022/08/16/methamphetamine-use-overdose-deaths-and-arrests-soared-from-2015-to-2019

National Center for Health Statistics US , Centers for Disease Control and Prevention . Provisional drug overdose death counts. Updated February 15, 2023. Accessed February 27, 2023. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

Huber A , Ling W , Shoptaw S , Gulati V , Brethen P , Rawson R . Integrating treatments for methamphetamine abuse: a psychosocial perspective. J Addict Dis. 1997; 16(4):41-50.

Anglin MD , Burke C , Perrochet B , Stamper E , Dawud-Noursi S . History of the methamphetamine problem. J Psychoactive Drugs. 2000; 32(2):137-141.